Fragile X mental retardation protein controls ion channel expression and activity

Journal of Physiology

Volumn 594, Issue 20, 2016, Pages 5861-5867

  Ferron, Laurent ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CHANNEL N TYPE; FRAGILE X MENTAL RETARDATION PROTEIN; ION CHANNEL; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MESSENGER RNA; PHOSPHOPROTEIN PHOSPHATASE 2A; POTASSIUM CHANNEL; S6 KINASE; SODIUM ACTIVATED POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL CAV2.2; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; CELL MEMBRANE; FRAGILE X SYNDROME; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REGULATORY RNA SEQUENCE; REVIEW; SYNAPTIC TRANSMISSION; UPREGULATION;

EID: 84991267096     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270675     Document Type: Review

References (64)

1. Akins MR, Berk-Rauch HE & Fallon JR (2009). Presynaptic translation: stepping out of the postsynaptic shadow. Front Neural Circuits 3, 17.
2. Akins MR, Leblanc HF, Stackpole EE, Chyung E & Fallon JR (2012). Systematic mapping of fragile X granules in the mouse brain reveals a potential role for presynaptic FMRP in sensorimotor functions. J Comp Neurol 520, 3687–3706.
3. Altier C, Dale CS, Kisilevsky AE, Chapman K, Castiglioni AJ, Matthews EA, Evans RM, Dickenson AH, Lipscombe D, Vergnolle N & Zamponi GW (2007). Differential role of N-type calcium channel splice isoforms in pain. J Neurosci 27, 6363–6373.
4. Antar LN, Afroz R, Dictenberg JB, Carroll RC & Bassell GJ (2004). Metabotropic glutamate receptor activation regulates Fragile X mental retardation protein and Fmr1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24, 2648–2655.
5. Antar LN, Li C, Zhang H, Carroll RC & Bassell GJ (2006). Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 32, 37–48.
6. Bagni C & Greenough WT (2005). From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 6, 376–387.
7. Bassell GJ & Warren ST (2008). Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201–214.
8. Bean BP (2007). The action potential in mammalian central neurons. Nat Rev Neurosci 8, 451–465.
9. Bezprozvanny I, Scheller RH & Tsien RW (1995). Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378, 623–626.
10. Bhakar AL, Dolen G & Bear MF (2012). The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 35, 417–443.
11. Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P & Klann E (2012). Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76, 325–337.
12. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX & Luther RR (1996). Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 279, 1243–1249.
13. Brager DH & Johnston D (2014). Channelopathies and dendritic dysfunction in fragile X syndrome. Brain Res Bull 103, 11–17.
14. Brenner R, Jegla TJ, Wickenden A, Liu Y & Aldrich RW (2000). Cloning and functional characterization of novel large conductance calcium-activated potassium channel β subunits, hKCNMB3 and hKCNMB4. J Biol Chem 275, 6453–6461.
15. Brown MR & Kaczmarek LK (2011). Potassium channel modulation and auditory processing. Hear Res 279, 32–42.
16. Brown MR, Kronengold J, Gazula VR, Chen Y, Strumbos JG, Sigworth FJ, Navaratnam D & Kaczmarek LK (2010). Fragile X mental retardation protein controls gating of the sodium-activated potassium channel Slack. Nat Neurosci 13, 819–821.
17. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB & Warren ST (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477–487.
18. Catterall WA & Few AP (2008). Calcium channel regulation and presynaptic plasticity. Neuron 59, 882–901.
19. Cheng L, Locke C & Davis GW (2011). S6 kinase localizes to the presynaptic active zone and functions with PDK1 to control synapse development. J Cell Biol 194, 921–935.
20. Christie SB, Akins MR, Schwob JE & Fallon JR (2009). The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J Neurosci 29, 1514–1524.
21. Contractor A, Klyachko VA & Portera-Cailliau C (2015). Altered neuronal and circuit excitability in fragile X syndrome. Neuron 87, 699–715.
22. 2+ channels, SNAP-25, and synaptotagmin. J Biol Chem 276, 32756–32762.
23. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST & Darnell RB (2001). Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489–499.
24. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, Stone EF, Chen C, Fak JJ, Chi SW, Licatalosi DD, Richter JD & Darnell RB (2011). FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261.
25. Deng PY & Klyachko VA (2016). Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome. J Physiol 594, 83–97.
26. Deng PY, Rotman Z, Blundon JA, Cho Y, Cui J, Cavalli V, Zakharenko SS & Klyachko VA (2013). FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels. Neuron 77, 696–711.
27. Deng PY, Sojka D & Klyachko VA (2011). Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J Neurosci 31, 10971–10982.
28. Dictenberg JB, Swanger SA, Antar LN, Singer RH & Bassell GJ (2008). A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 14, 926–939.
29. 2δ and β subunits: trafficking and one step beyond. Nat Rev Neurosci 13, 542–555.
30. Ferron L, Nieto-Rostro M, Cassidy JS & Dolphin AC (2014). Fragile X mental retardation protein controls synaptic vesicle exocytosis by modulating N-type calcium channel density. Nat Commun 5, 3628.
31. 2+ signalling regulates aldosterone-induced CREB activation and cell death through PP2A activation in neonatal cardiomyocytes. Cardiovasc Res 90, 105–112.
32. Gross C, Yao X, Pong DL, Jeromin A & Bassell GJ (2011). Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2. J Neurosci 31, 5693–5698.
33. Hagerman R & Hagerman P (2013). Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol 12, 786–798.
34. Hanson JE & Madison DV (2007). Presynaptic Fmr1 genotype influences the degree of synaptic connectivity in a mosaic mouse model of fragile X syndrome. J Neurosci 27, 4014–4018.
35. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 239, 57–61.
36. 2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell 144, 282–295.
37. Kim GE & Kaczmarek LK (2014). Emerging role of the KCNT1 Slack channel in intellectual disability. Front Cell Neurosci 8, 209.
38. Klemmer P, Meredith RM, Holmgren CD, Klychnikov OI, Stahl-Zeng J, Loos M, van der Schors RC, Wortel J, de Wit H, Spijker S, Rotaru DC, Mansvelder HD, Smit AB & Li KW (2011). Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype. J Biol Chem 286, 25495–25504.
39. Krueger DD & Bear MF (2011). Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med 62, 411–429.
40. Lee A, Fakler B, Kaczmarek LK & Isom LL (2014). More than a pore: ion channel signaling complexes. J Neurosci 34, 15159–15169.
41. Lee HY, Ge WP, Huang W, He Y, Wang GX, Rowson-Baldwin A, Smith SJ, Jan YN & Jan LY (2011). Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Neuron 72, 630–642.
42. Liao L, Park SK, Xu T, Vanderklish P & Yates JR III (2008). Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci USA 105, 15281–15286.
43. Lozano R, Rosero CA & Hagerman RJ (2014). Fragile X spectrum disorders. Intractable Rare Dis Res 3, 134–146.
44. Maximov A, Sudhof TC & Bezprozvanny I (1999). Association of neuronal calcium channels with modular adaptor proteins. J Biol Chem 274, 24453–24456.
45. Menon RP, Gibson TJ & Pastore A (2004). The C terminus of fragile X mental retardation protein interacts with the multi-domain Ran-binding protein in the microtubule-organising centre. J Mol Biol 343, 43–53.
46. 2+ channels. Neuron 17, 781–788.
47. Mochida S, Westenbroek RE, Yokoyama CT, Zhong H, Myers SJ, Scheuer T, Itoh K & Catterall WA (2003). Requirement for the synaptic protein interaction site for reconstitution of synaptic transmission by P/Q-type calcium channels. Proc Natl Acad Sci USA 100, 2819–2824.
48. Muddashetty RS, Kelic S, Gross C, Xu M & Bassell GJ (2007). Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 27, 5338–5348.
49. Myrick LK, Deng PY, Hashimoto H, Oh YM, Cho Y, Poidevin MJ, Suhl JA, Visootsak J, Cavalli V, Jin P, Cheng X, Warren ST & Klyachko VA (2015). Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures. Proc Natl Acad Sci USA 112, 949–956.
50. Narayanan U, Nalavadi V, Nakamoto M, Pallas DC, Ceman S, Bassell GJ & Warren ST (2007). FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J Neurosci 27, 14349–14357.
51. Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell GJ & Warren ST (2008). S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade. J Biol Chem 283, 18478–18482.
52. Pretto DI, Eid JS, Yrigollen CM, Tang HT, Loomis EW, Raske C, Durbin-Johnson B, Hagerman PJ & Tassone F (2015). Differential increases of specific FMR1 mRNA isoforms in premutation carriers. J Med Genet 52, 42–52.
53. Price TJ, Flores CM, Cervero F & Hargreaves KM (2006). The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons. Neuroscience 141, 2107–2116.
54. Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM & Cervero F (2007). Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J Neurosci 27, 13958–13967.
55. Ramos A, Hollingworth D, Adinolfi S, Castets M, Kelly G, Frenkiel TA, Bardoni B & Pastore A (2006). The structure of the N-terminal domain of the fragile X mental retardation protein: a platform for protein-protein interaction. Structure 14, 21–31.
56. Ronesi JA & Huber KM (2008). Metabotropic glutamate receptors and fragile X mental retardation protein: partners in translational regulation at the synapse. Sci Signal 1, e6.
57. Sheng ZH, Rettig J, Takahashi M & Catterall WA (1994). Identification of a syntaxin-binding site on N-type calcium channels. Neuron 13, 1303–1313.
58. Strumbos JG, Brown MR, Kronengold J, Polley DB & Kaczmarek LK (2010). Fragile X mental retardation protein is required for rapid experience-dependent regulation of the potassium channel Kv3.1b. J Neurosci 30, 10263–10271.
59. V2.2 in hippocampal neurons. Eur J Neurosci 24, 709–718.
60. + channels. J Biol Chem 282, 24485–24489.
61. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA 90, 9518–9522.
62. Viquez NM, Fuger P, Valakh V, Daniels RW, Rasse TM & DiAntonio A (2009). PP2A and GSK-3β act antagonistically to regulate active zone development. J Neurosci 29, 11484–11494.
63. Na channels regulate the accuracy of timing of auditory neurons. J Neurosci 27, 2617–2627.
64. Zhang Y, Brown MR, Hyland C, Chen Y, Kronengold J, Fleming MR, Kohn AB, Moroz LL & Kaczmarek LK (2012). Regulation of neuronal excitability by interaction of fragile X mental retardation protein with Slack potassium channels. J Neurosci 32, 15318–15327.